Critically needed is for the clinical and scientific community to contemplate new strategies to address antimicrobial-resistant pathogens. Antibiotic susceptibility tests (ASTs) that use molecular technologies like RNA-seq to significantly improve treatment of bacterial infections at the point of care. These are more accurate than their agar-based counterparts and can be delivered in minutes instead of days.